한글목차

저분자 신약 개발 시장 규모는 최근 급성장하고 있습니다. 2025년 679억 4,000만 달러에서 2026년에는 755억 6,000만 달러에 이르고, CAGR 11.2%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 제약사의 R&D 투자 증가, 만성질환 유병률 증가, 분자생물학 기술의 발전, 비용 효율적인 치료법에 대한 수요 증가, 임상시험수탁기관(CRO)의 부상 등이 주요 요인으로 작용한 것으로 분석됩니다.

저분자 의약품 Drug Discovery 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 1,170억 5,000만 달러에 이르고, CAGR은 11.6%를 나타낼 전망입니다. 예측 기간 동안의 성장은 신약개발 분야에서 AI와 머신러닝의 통합, 정밀의료 이니셔티브의 확대, 생명공학 기업과 제약 기업 간의 협력 강화, 자동화된 하이스루풋 플랫폼의 도입, 희귀질환 및 복합질환에 대한 관심 증가에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 하이스루풋 스크리닝의 도입, 조합 화학의 발전, 신약 설계에 나노기술의 통합, 개인 맞춤형 의료의 개발, 표적 검증 및 리드 화합물 최적화의 강화 등이 있습니다.

만성질환의 유병률 증가는 향후 저분자 의약품 창출 시장의 성장을 가속할 것으로 예측됩니다. 만성질환은 1년 이상 지속되어 일상생활에 지장을 주거나 지속적인 의료적 치료가 필요한 상태, 또는 이 두 가지 모두에 해당되는 상태를 말합니다. 저분자 의약품은 HIV, 암, 감염성 질환, 심장병, 신장 질환 등 만성 질환 치료에 사용되며, 일반적으로 장기적인 질환을 앓고 있는 환자들에게 보다 저렴한 가격대로 제공됩니다. 따라서 만성질환의 발생률 증가는 저분자 신약 시장의 성장을 뒷받침할 것으로 예측됩니다. 예를 들어, 미국 국립보건원(NIH)의 2023년 보고서에 따르면, 2050년까지 미국에서 50세 이상 만성질환을 앓고 있는 50세 이상 인구는 1억 4,266만 명에 달할 것으로 예상되고 있습니다. 또한, 여러 만성질환을 앓고 있는 인구는 2050년까지 1,496만 8,000명으로 증가할 것으로 예측되고 있습니다. 따라서 만성 질환의 유병률 증가는 저분자 신약 개발 시장의 주요 촉진요인입니다.

저분자 신약개발 분야의 주요 기업들은 시장에서의 수익 확대를 목적으로 제휴 관계를 구축하고 있습니다. 이러한 제휴는 서로 다른 조직의 강점을 결합하여 혁신을 촉진하는 경우가 많습니다. 예를 들어, 2023년 11월 미국 비영리단체인 에보뮨(EvoMune)과 미국 생명공학 기업 어큐터 바이오테크놀러지(Accutane Biotechnology)는 만성 염증성 질환을 대상으로 한 AI 기반 신약개발에 초점을 맞춘 전략적 제휴를 발표했습니다. 이번 제휴는 Accutane의 독자적인 AI 플랫폼과 EvoMune의 전문성을 활용하여 저분자 신약 후보물질을 발굴하는 것을 목표로 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Small Molecule Drug Discovery is the process of identifying and developing low molecular weight compounds that can interact with specific biological targets to treat diseases. This approach is used to create effective medications capable of modulating biological pathways, ultimately leading to improved therapeutic outcomes.

The primary drug types in small molecule drug discovery include small molecule drugs and biologic drugs. A small-molecule drug is any organic chemical with a molecular weight of less than 900 daltons that can influence a biological process. Various technologies such as high throughput screening, pharmacogenomics, combinatorial chemistry, and nanotechnology are employed across a range of therapeutic areas, including oncology, central nervous system disorders, cardiovascular conditions, respiratory issues, metabolic disorders, and gastrointestinal diseases, among others. The process typically follows several phases, including target identification or validation, hit generation and selection, lead identification, and lead optimization, with pharmaceutical companies, contract research organizations, and other entities involved in these stages.

Tariffs have impacted the small molecule drug discovery market by increasing the cost of importing critical reagents, laboratory equipment, and chemical intermediates, leading to supply chain disruptions. Asia-Pacific regions, particularly China and India, are most affected due to their role in providing raw materials and APIs. Segments such as high-throughput screening and combinatorial chemistry face higher operational costs, while pharmaceutical companies are exploring local sourcing and regional manufacturing to mitigate risks. Positive impacts include encouraging domestic production and boosting local contract research capabilities.

The small molecule drug discovery market research report is one of a series of new reports from The Business Research Company that provides small molecule drug discovery market statistics, including small molecule drug discovery industry global market size, regional shares, competitors with a small molecule drug discovery market share, detailed small molecule drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule drug discovery industry. This small molecule drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule drug discovery market size has grown rapidly in recent years. It will grow from $67.94 billion in 2025 to $75.56 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing r&d investments by pharmaceutical companies, growth in chronic disease prevalence, advancements in molecular biology techniques, rising demand for cost-effective therapeutics, emergence of contract research organizations (cros).

The small molecule drug discovery market size is expected to see rapid growth in the next few years. It will grow to $117.05 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to integration of ai and machine learning in drug discovery, expansion of precision medicine initiatives, increasing collaborations between biotech and pharma, adoption of automated high-throughput platforms, growing focus on rare and complex diseases. Major trends in the forecast period include high-throughput screening adoption, combinatorial chemistry advancements, nanotechnology integration in drug design, personalized medicine development, target validation and lead optimization enhancements.

The increasing prevalence of chronic diseases is expected to drive the growth of the small molecule drug discovery market in the future. Chronic diseases are conditions that last for a year or more, hinder daily activities, and require ongoing medical care, or both. Small-molecule medications can be used to treat chronic conditions such as HIV, cancer, infections, heart disease, and renal disease, and they are generally more affordable for patients dealing with these long-term conditions. Consequently, the rising incidence of chronic diseases is anticipated to support the growth of the small molecule drug discovery market. For example, according to a 2023 report by the National Institutes of Health (NIH), a US-based biomedical research agency, the number of individuals aged 50 and older with at least one chronic illness in the United States is expected to reach 142.66 million by 2050. Furthermore, the population with multimorbidity is projected to grow to 14.968 million by 2050. Therefore, the increasing prevalence of chronic diseases is a key driver of the small molecule drug discovery market.

Leading companies in small molecule drug discovery are forming partnerships to boost revenues in the market. These partnerships often encourage innovation by combining the strengths of different organizations. For instance, in November 2023, Evommune, a US-based non-profit organization, and Accutar Biotechnology, a US-based biotechnology company, announced a strategic collaboration focused on AI-driven drug discovery for chronic inflammatory diseases. This partnership aims to use Accutar's proprietary AI platform alongside Evommune's expertise to identify novel small molecule drug candidates.

In April 2025, Johnson & Johnson, a US-based biopharmaceutical company that offers prescription pharmaceuticals, medical devices, and consumer health products, acquired Intra Cellular Therapies, Inc. for an undisclosed sum. This acquisition is intended to strengthen Johnson & Johnson's neuroscience portfolio, expand its small-molecule central nervous system therapeutic capabilities, and accelerate growth in mental health and neurodegenerative disease treatments. Intra Cellular Therapies, Inc. is a US-based biopharmaceutical company focused on developing small-molecule drugs for the central nervous system, including treatments for psychiatric and neurodegenerative disorders.

Major companies operating in the small molecule drug discovery market are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Allarity Therapeutics, Cyteir Therapeutics, BigHat Biosciences

North America was the largest region in the small molecule drug discovery market in 2025. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecule drug discovery market consists of sales of diphenhydramine, aspirin, and other "medicine cabinet" drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule Drug Discovery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses small molecule drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The small molecule drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Type: Small Molecule Drugs; Biologic Drugs
• 2) By Technology: High Throughput Screening; Pharmacogenomics; Combinatorial Chemistry; Nanotechnology; Others
• 3) By Therapeutic Area: Oncology; Central Nervous System; Cardiovascular; Respiratory; Metabolic Disorders; Gastrointestinal; Others
• 4) By Process Or Phase: Target ID Or Validation; Hit Generation And Selection; Lead Identification; Lead Optimization
• 5) By End-User: Pharmaceutical Companies; Contract Research Organizations; Others
• Subsegments:
• 1) By Small Molecule Drugs: Generic Small Molecule Drugs; Novel Small Molecule Drugs
• 2) By Biologic Drugs: Monoclonal Antibodies; Vaccines; Recombinant Proteins; Cell And Gene Therapies
• Companies Mentioned: Pfizer Inc.; GlaxoSmithKline plc; AstraZeneca; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Johnson & Johnson; Gilead Sciences Inc.; Merck KGaA; Novartis AG; 4SC AG; Teva Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited; Labcorp Drug Development; ICON Public Limited Company; Charles River Laboratories; Aluda Pharmaceuticals; Corcept Therapeutics; Edison Oncology; Escend Pharmaceuticals; Terray Therapeutics; Apollomics; Astex Pharmaceuticals; Pardes Biosciences; Xynomic Pharmaceuticals; Zevra Therapeutics; UNION therapeutics; Allarity Therapeutics; Cyteir Therapeutics; BigHat Biosciences
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Small Molecule Drug Discovery Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Small Molecule Drug Discovery Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Small Molecule Drug Discovery Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Small Molecule Drug Discovery Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 High-Throughput Screening Adoption
  • 4.2.2 Combinatorial Chemistry Advancements
  • 4.2.3 Nanotechnology Integration in Drug Design
  • 4.2.4 Personalized Medicine Development
  • 4.2.5 Target Validation and Lead Optimization Enhancements

5. Small Molecule Drug Discovery Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Contract Research Organizations (CROs)
• 5.4 Academic and Research Institutions
• 5.5 Diagnostic Laboratories

6. Small Molecule Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Small Molecule Drug Discovery Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Small Molecule Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Small Molecule Drug Discovery Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Small Molecule Drug Discovery Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Small Molecule Drug Discovery Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Small Molecule Drug Discovery Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Small Molecule Drug Discovery Market Segmentation

• 9.1. Global Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Small Molecule Drugs, Biologic Drugs
• 9.2. Global Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
• 9.3. Global Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
• 9.4. Global Small Molecule Drug Discovery Market, Segmentation By Process Or Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
• 9.5. Global Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Contract Research Organizations, Others
• 9.6. Global Small Molecule Drug Discovery Market, Sub-Segmentation Of Small Molecule Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Generic Small Molecule Drugs, Novel Small Molecule Drugs
• 9.7. Global Small Molecule Drug Discovery Market, Sub-Segmentation Of Biologic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

10. Small Molecule Drug Discovery Market Regional And Country Analysis

• 10.1. Global Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Small Molecule Drug Discovery Market

• 11.1. Asia-Pacific Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Small Molecule Drug Discovery Market

• 12.1. China Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Small Molecule Drug Discovery Market

• 13.1. India Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Small Molecule Drug Discovery Market

• 14.1. Japan Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Small Molecule Drug Discovery Market

• 15.1. Australia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Small Molecule Drug Discovery Market

• 16.1. Indonesia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Small Molecule Drug Discovery Market

• 17.1. South Korea Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Small Molecule Drug Discovery Market

• 18.1. Taiwan Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Small Molecule Drug Discovery Market

• 19.1. South East Asia Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Small Molecule Drug Discovery Market

• 20.1. Western Europe Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Small Molecule Drug Discovery Market

• 21.1. UK Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Small Molecule Drug Discovery Market

• 22.1. Germany Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Small Molecule Drug Discovery Market

• 23.1. France Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Small Molecule Drug Discovery Market

• 24.1. Italy Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Small Molecule Drug Discovery Market

• 25.1. Spain Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Small Molecule Drug Discovery Market

• 26.1. Eastern Europe Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Small Molecule Drug Discovery Market

• 27.1. Russia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Small Molecule Drug Discovery Market

• 28.1. North America Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Small Molecule Drug Discovery Market

• 29.1. USA Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Small Molecule Drug Discovery Market

• 30.1. Canada Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Small Molecule Drug Discovery Market

• 31.1. South America Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Small Molecule Drug Discovery Market

• 32.1. Brazil Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Small Molecule Drug Discovery Market

• 33.1. Middle East Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Small Molecule Drug Discovery Market

• 34.1. Africa Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Small Molecule Drug Discovery Market, Segmentation By Drug Type, Segmentation By Technology, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Small Molecule Drug Discovery Market Regulatory and Investment Landscape

36. Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles

• 36.1. Small Molecule Drug Discovery Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Small Molecule Drug Discovery Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Small Molecule Drug Discovery Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

37. Small Molecule Drug Discovery Market Other Major And Innovative Companies

• Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics

38. Global Small Molecule Drug Discovery Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Small Molecule Drug Discovery Market

40. Small Molecule Drug Discovery Market High Potential Countries, Segments and Strategies

• 40.1 Small Molecule Drug Discovery Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Small Molecule Drug Discovery Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Small Molecule Drug Discovery Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer